S&E bio Co., Ltd., a biotechnology company specializing in exosomal microRNA-based therapies, has received approval from Korea's Ministry of Food and Drug Safety (MFDS) to initiate a Phase 1b clinical ...

By Shreya Dasgupta Massive wildfires that killed at least 32 people and scorched an area nearly double the size of Seoul in ...